Targeting Sec61 to Silence Pathogenic Light-Chain Production in AL Amyloidosis
Daniela Ricci, Chloé Veront, Irene VALCOZZENA, Merlin Després, Alice Nevone, Marine Oberkampf, Mariette Matondo, Karen Druart, Thibaut Douché, Sarra Loulizi, David Hardy, Florence Bugault, Manon Capdeville, Mario Nuvolone, Caroline Demangel
This study targets the Sec61 translocon to suppress pathogenic light-chain production in AL amyloidosis, showing that mycolactone and synthetic inhibitors like A317 reduce LC secretion while highlighting the need for client selectivity.
bioRxiv · Sep 13, 2026 · PreprintCell Biology